OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
Deep Dutta, Anshita Agarwal, Indira Maisnam, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 2, pp. 374-387
Open Access | Times Cited: 38
Deep Dutta, Anshita Agarwal, Indira Maisnam, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 2, pp. 374-387
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
Semaglutide and cancer: A systematic review and meta-analysis
Lakshmi Nagendra, BG Harish, Meha Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 9, pp. 102834-102834
Closed Access | Times Cited: 36
Lakshmi Nagendra, BG Harish, Meha Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 9, pp. 102834-102834
Closed Access | Times Cited: 36
Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis
Deep Dutta, Lakshmi Nagendra, Ameya Joshi, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1653-1664
Closed Access | Times Cited: 13
Deep Dutta, Lakshmi Nagendra, Ameya Joshi, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1653-1664
Closed Access | Times Cited: 13
Orforglipron, a novel non‐peptide oral daily glucagon‐like peptide‐1 receptor agonist as an anti‐obesity medicine: A systematic review and meta‐analysis
Deep Dutta, Lakshmi Nagendra, Beatrice Anne, et al.
Obesity Science & Practice (2024) Vol. 10, Iss. 2
Open Access | Times Cited: 10
Deep Dutta, Lakshmi Nagendra, Beatrice Anne, et al.
Obesity Science & Practice (2024) Vol. 10, Iss. 2
Open Access | Times Cited: 10
Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: A Cochrane meta-analysis
Deep Dutta, Vineet Surana, Rajiv Singla, et al.
Indian Journal of Endocrinology and Metabolism (2021) Vol. 25, Iss. 6, pp. 475-489
Open Access | Times Cited: 43
Deep Dutta, Vineet Surana, Rajiv Singla, et al.
Indian Journal of Endocrinology and Metabolism (2021) Vol. 25, Iss. 6, pp. 475-489
Open Access | Times Cited: 43
Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis
Deep Dutta, Saptarshi Bhattacharya, M. Kumar, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 17, Iss. 1, pp. 102697-102697
Closed Access | Times Cited: 25
Deep Dutta, Saptarshi Bhattacharya, M. Kumar, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 17, Iss. 1, pp. 102697-102697
Closed Access | Times Cited: 25
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
Kyung‐Soo Kim, Kyung Ah Han, Tae Nyun Kim, et al.
Diabetes & Metabolism (2023) Vol. 49, Iss. 4, pp. 101440-101440
Open Access | Times Cited: 14
Kyung‐Soo Kim, Kyung Ah Han, Tae Nyun Kim, et al.
Diabetes & Metabolism (2023) Vol. 49, Iss. 4, pp. 101440-101440
Open Access | Times Cited: 14
Impact of early initiation of ezetimibe in patients with acute coronary syndrome: A systematic review and meta-analysis
Kunal Mahajan, Lakshmi Nagendra, Anil Dhall, et al.
European Journal of Internal Medicine (2024) Vol. 124, pp. 99-107
Closed Access | Times Cited: 4
Kunal Mahajan, Lakshmi Nagendra, Anil Dhall, et al.
European Journal of Internal Medicine (2024) Vol. 124, pp. 99-107
Closed Access | Times Cited: 4
Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis
Deep Dutta, Lakshmi Nagendra, BG Harish, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 5, pp. 436-444
Open Access | Times Cited: 3
Deep Dutta, Lakshmi Nagendra, BG Harish, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 5, pp. 436-444
Open Access | Times Cited: 3
Efficacy and Safety of Tocilizumab in Polymyalgia Rheumatica: A Systematic Review and Meta‐Analysis
Meha Sharma, Siddharth Kumar Das, Ritin Mohindra, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Meha Sharma, Siddharth Kumar Das, Ritin Mohindra, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study
Soo Lim, Minji Sohn, José C. Florez, et al.
Nutrients (2023) Vol. 15, Iss. 1, pp. 248-248
Open Access | Times Cited: 8
Soo Lim, Minji Sohn, José C. Florez, et al.
Nutrients (2023) Vol. 15, Iss. 1, pp. 248-248
Open Access | Times Cited: 8
Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes
Ranakishor Pelluri, S. Kongara, Vanitha Rani Nagasubramanian, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 5, pp. 855-867
Closed Access | Times Cited: 6
Ranakishor Pelluri, S. Kongara, Vanitha Rani Nagasubramanian, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 5, pp. 855-867
Closed Access | Times Cited: 6
Verapamil improves One-Year C-Peptide Levels in Recent Onset Type-1 Diabetes: A Meta-Analysis
Deep Dutta, Lakshmi Nagendra, Nishant Raizada, et al.
Indian Journal of Endocrinology and Metabolism (2023) Vol. 27, Iss. 3, pp. 192-200
Open Access | Times Cited: 6
Deep Dutta, Lakshmi Nagendra, Nishant Raizada, et al.
Indian Journal of Endocrinology and Metabolism (2023) Vol. 27, Iss. 3, pp. 192-200
Open Access | Times Cited: 6
Role of novel sodium glucose co-transporter-2 inhibitor enavogliflozin in type-2 diabetes: A systematic review and meta-analysis
Deep Dutta, B.G. Harish, Beatrice Anne, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 8, pp. 102816-102816
Closed Access | Times Cited: 5
Deep Dutta, B.G. Harish, Beatrice Anne, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 8, pp. 102816-102816
Closed Access | Times Cited: 5
Optimal use of once weekly icodec insulin in type-2 diabetes: An updated meta-analysis of phase-2 and phase-3 randomized controlled trials
Deep Dutta, Lakshmi Nagendra, Sowrabha Bhat, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 10, pp. 102877-102877
Closed Access | Times Cited: 5
Deep Dutta, Lakshmi Nagendra, Sowrabha Bhat, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 10, pp. 102877-102877
Closed Access | Times Cited: 5
Impact of early initiation of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with acute coronary syndrome: A systematic review meta-analysis
Lakshmi Nagendra, Kunal Mahajan, Gunjan Gupta, et al.
Indian Heart Journal (2023) Vol. 75, Iss. 6, pp. 416-422
Open Access | Times Cited: 4
Lakshmi Nagendra, Kunal Mahajan, Gunjan Gupta, et al.
Indian Heart Journal (2023) Vol. 75, Iss. 6, pp. 416-422
Open Access | Times Cited: 4
Long-Term Impact on Offspring (5 to 11 Years of Age) of Metformin Use in Pregnancy in Mothers With Diabetes: A Systematic Review and Meta-Analysis
Deep Dutta, Meha Sharma, Lakshmi Nagendra, et al.
Endocrine Practice (2024) Vol. 30, Iss. 9, pp. 854-862
Closed Access | Times Cited: 1
Deep Dutta, Meha Sharma, Lakshmi Nagendra, et al.
Endocrine Practice (2024) Vol. 30, Iss. 9, pp. 854-862
Closed Access | Times Cited: 1
Optimal use of once-weekly basal insulin efsitora alfa in type 1 and type 2 diabetes: A systematic review and meta-analysis
Deep Dutta, Lakshmi Nagendra, Manoj Kumar, et al.
Endocrine Practice (2024)
Closed Access | Times Cited: 1
Deep Dutta, Lakshmi Nagendra, Manoj Kumar, et al.
Endocrine Practice (2024)
Closed Access | Times Cited: 1
Efficacy and safety of dorzagliatin, a novel glucokinase activators, in the treatment of T2DM: A meta-analysis of randomized controlled trials
Yuqian Wu, Kai Wang, Jingyang Su, et al.
Medicine (2024) Vol. 103, Iss. 8, pp. e36916-e36916
Open Access | Times Cited: 1
Yuqian Wu, Kai Wang, Jingyang Su, et al.
Medicine (2024) Vol. 103, Iss. 8, pp. e36916-e36916
Open Access | Times Cited: 1
Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression
Kyeong‐Min Lee, Yeo Jin Hwang, Gwon‐Soo Jung
Biochemical and Biophysical Research Communications (2022) Vol. 626, pp. 135-141
Closed Access | Times Cited: 6
Kyeong‐Min Lee, Yeo Jin Hwang, Gwon‐Soo Jung
Biochemical and Biophysical Research Communications (2022) Vol. 626, pp. 135-141
Closed Access | Times Cited: 6
Efficacy and safety of hydroxychloroquine for managing glycemia in type-2 diabetes: A systematic review and meta-analysis
Deep Dutta, Radhika Jindal, Divij Mehta, et al.
Journal of Postgraduate Medicine (2022) Vol. 68, Iss. 2, pp. 85-92
Open Access | Times Cited: 4
Deep Dutta, Radhika Jindal, Divij Mehta, et al.
Journal of Postgraduate Medicine (2022) Vol. 68, Iss. 2, pp. 85-92
Open Access | Times Cited: 4
Hyperprolactinemia Due to Prolactinoma has an Adverse Impact on Bone Health with Predominant Impact on Trabecular Bone: A Systematic Review and Meta-Analysis
Lakshmi Nagendra, Deep Dutta, Sunetra Mondal, et al.
Journal of Clinical Densitometry (2023) Vol. 27, Iss. 1, pp. 101453-101453
Closed Access | Times Cited: 2
Lakshmi Nagendra, Deep Dutta, Sunetra Mondal, et al.
Journal of Clinical Densitometry (2023) Vol. 27, Iss. 1, pp. 101453-101453
Closed Access | Times Cited: 2
Safety and efficacy of once weekly dipeptidyl-peptidase-4 inhibitor trelagliptin in type-2 diabetes: A meta-analysis
Deep Dutta, Ritin Mohindra, Vineet Surana, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 4, pp. 102469-102469
Closed Access | Times Cited: 3
Deep Dutta, Ritin Mohindra, Vineet Surana, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 4, pp. 102469-102469
Closed Access | Times Cited: 3
Efficacy and safety of novel dual glucokinase activator dorzagliatin in type-2 diabetes A meta-analysis
Deep Dutta, Deepak Khandelwal, Manoj Kumar, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 17, Iss. 1, pp. 102695-102695
Closed Access | Times Cited: 3
Deep Dutta, Deepak Khandelwal, Manoj Kumar, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 17, Iss. 1, pp. 102695-102695
Closed Access | Times Cited: 3
Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in children and young adults: a systematic review and meta-analysis
Lakshmi Nagendra, Deep Dutta, BG Harish, et al.
Annals of Pediatric Endocrinology & Metabolism (2024) Vol. 29, Iss. 2, pp. 82-89
Open Access
Lakshmi Nagendra, Deep Dutta, BG Harish, et al.
Annals of Pediatric Endocrinology & Metabolism (2024) Vol. 29, Iss. 2, pp. 82-89
Open Access
Impact of pheochromocytoma or paraganglioma on bone metabolism: A systemic review and meta-analysis
Deep Dutta, Lakshmi Nagendra, Manju Chandran, et al.
Journal of Clinical Densitometry (2024) Vol. 27, Iss. 3, pp. 101501-101501
Closed Access
Deep Dutta, Lakshmi Nagendra, Manju Chandran, et al.
Journal of Clinical Densitometry (2024) Vol. 27, Iss. 3, pp. 101501-101501
Closed Access
